Cargando…
Shrinking Weibel‐Palade bodies prevents high platelet recruitment in assays using thrombotic thrombocytopenic purpura plasma
BACKGROUND: Thrombotic thrombocytopenic purpura (TTP), caused by a genetic or autoimmune‐driven lack of ADAMTS‐13 activity, leads to high levels of the ultra‐large von Willebrand factor (VWF) multimers produced by endothelial cells, causing excess platelet recruitment into forming thrombi, often wit...
Autores principales: | Patella, Francesca, Vendramin, Chiara, Charles, Oscar, Scully, Marie A., Cutler, Daniel F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652131/ https://www.ncbi.nlm.nih.gov/pubmed/34934893 http://dx.doi.org/10.1002/rth2.12626 |
Ejemplares similares
-
Bethesda Assay for Detecting Inhibitory Anti-ADAMTS13 Antibodies in Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Vendramin, Chiara, et al.
Publicado: (2018) -
Quantitative analysis of Weibel-Palade bodies
por: Liu, Alice, et al.
Publicado: (2022) -
Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura
por: Alwan, Ferras, et al.
Publicado: (2021) -
Management of thrombotic thrombocytopenic purpura: current perspectives
por: Blombery, Piers, et al.
Publicado: (2014) -
Recombinant ADAMTS 13 in thrombotic thrombocytopenic purpura
por: Scully, Marie, et al.
Publicado: (2017)